In the third edition of The MCCRC Podcast, Dr. Kim Kuebler sits down with Dr. Matthew Sorenson to talk about how the human body is impacted by chronic conditions, the different types of cells in the immune system, and the factors impacting immune health. Visit The Multiple Chronic Conditions Website here: https://multiplechronicconditions.org/

In the third edition of The MCCRC Podcast, Dr. Kim Kuebler sits down with Dr. Matthew Sorenson to talk about how the human body is impacted by chronic conditions, the different types of cells in the immune system, and the factors impacting immune health. Visit The Multiple Chronic Conditions Website here: https://multiplechronicconditions.org/

Multiple Chronic Conditions (MCC) means that a person is living with two or more chronic conditions at the same time. Currently, 1 out of 3 adult Americans have MCCs and for persons 65 and older 4 out of 5 Medicare Beneficiaries and a growing number of children have MCCs. This is the largest patient population and users of healthcare resources accounting for 64% of all clinician visits, 70% of all inpatient stays, 83% of all prescriptions, 71% of all healthcare spending, and 93% of Medicare spending.

https://multiplechronicconditions.org/

Multiple Chronic Conditions (MCC) means that a person is living with two or more chronic conditions at the same time. Currently, 1 out of 3 adult Americans have MCCs and for persons 65 and older 4 out of 5 Medicare Beneficiaries and a growing number of children have MCCs. This is the largest patient population and users of healthcare resources accounting for 64% of all clinician visits, 70% of all inpatient stays, 83% of all prescriptions, 71% of all healthcare spending, and 93% of Medicare spending.
<a href="https://multiplechronicconditions.org/">https://multiplechronicconditions.org/</a>

Multiple Chronic Conditions | Resource Center

HealthCom Media is a leading healthcare information and content development company with a record of excellence in integrated marketing solutions that reach 3 million healthcare professionals each year.

We’re the official media partner of the American Nurse Journal, the official journal of the American Nurses Association (ANA), Nurse Practitioners in Women’s Healthcare (NPWH/NPs), and the American Association of Nurse Anesthetists (AANA/CRNAs).

HealthCom Media is a leading healthcare information and content development company with a record of excellence in integrated marketing solutions that reach 3 million healthcare professionals each year.
We’re the official media partner of the American Nurse Journal, the official journal of the American Nurses Association (ANA), Nurse Practitioners in Women’s Healthcare (NPWH/NPs), and the American Association of Nurse Anesthetists (AANA/CRNAs).

HealthCom Media

Dr. Matthew Sorenson discusses how the human immune system relates to Multiple Chronic Conditions

Write, Submit, Succeed is a conversational podcast designed to help nurses transform their clinical experience and insights into meaningful, published work. Whether you’ve never written a manuscript or have started but aren’t sure how to move forward, this series offers practical guidance, honest advice, and encouragement at every step. Through engaging, down-to-earth conversations with editors, we break down the writing and publication process into manageable, achievable steps. From identifying your idea and getting started, to overcoming common barriers, navigating peer review, and successfully submitting your work—we’re here to demystify the journey. At its core, Write, Submit, Succeed: A Nurse’s Podcast is about amplifying the voice of nurses. Your insights, experiences, and expertise matter—and they deserve to be shared. Other nurses want to learn from your successes and understand how you made it happen. This podcast provides the tools, confidence, and support to help you move from “I’ve been thinking about writing” to “I got published.”

Write, Submit, Succeed is a conversational podcast designed to help nurses transform their clinical experience and insights into meaningful, published work. Whether you&rsquo;ve never written a manuscript or have started but aren&rsquo;t sure how to move forward, this series offers practical guidance, honest advice, and encouragement at every step. Through engaging, down-to-earth conversations with editors, we break down the writing and publication process into manageable, achievable steps. From identifying your idea and getting started, to overcoming common barriers, navigating peer review, and successfully submitting your work&mdash;we&rsquo;re here to demystify the journey. At its core, Write, Submit, Succeed: A Nurse&rsquo;s Podcast is about amplifying the voice of nurses. Your insights, experiences, and expertise matter&mdash;and they deserve to be shared. Other nurses want to learn from your successes and understand how you made it happen. This podcast provides the tools, confidence, and support to help you move from &ldquo;I&rsquo;ve been thinking about writing&rdquo; to &ldquo;I got published.&rdquo;

Write, Submit, Succeed Ep 4: Barriers to Getting Started

The APOL1 gene is recognized as a kidney risk gene. APOL1-mediated kidney disease is a rapidly progressive form of proteinuria kidney disease. Although this gene is autosomal recessive the risk comes from the genotype of both parents. Compared with other chronic kidney disease patients, those of African ancestry with a confirmed APOL1 gene variant progress to dialysis 9 to 12 years earlier. APOL1-mediated kidney disease is often associated not only with proteinuria but also with a rapid decline in eGFR, earlier onset of kidney disease (including adolescence), and leads to a mean age of kidney failure in the U.S. of 45 years. Patients are often asymptomatic. Richard Knight, co-founder of the APOL-1 Alliance (https://apol1alliance.org/), provides a patient perspective on this condition.

The APOL1 gene is recognized as a kidney risk gene. APOL1-mediated kidney disease is a rapidly progressive form of proteinuria kidney disease. Although this gene is autosomal recessive the risk comes from the genotype of both parents. Compared with other chronic kidney disease patients, those of African ancestry with a confirmed APOL1 gene variant progress to dialysis 9 to 12 years earlier. APOL1-mediated kidney disease is often associated not only with proteinuria but also with a rapid decline in eGFR, earlier onset of kidney disease (including adolescence), and leads to a mean age of kidney failure in the U.S. of 45 years. Patients are often asymptomatic. Richard Knight, co-founder of the APOL-1 Alliance (https://apol1alliance.org/), provides a patient perspective on this condition.

Dr. Matthew Sorenson discusses how the human immune system relates to Multiple Chronic Conditions

In 1 playlist(s)

HealthCom Media

Recent clips